0001140361-12-052552.txt : 20121221 0001140361-12-052552.hdr.sgml : 20121221 20121221193306 ACCESSION NUMBER: 0001140361-12-052552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121219 FILED AS OF DATE: 20121221 DATE AS OF CHANGE: 20121221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIMICK NEIL F CENTRAL INDEX KEY: 0001248380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 121283331 MAIL ADDRESS: STREET 1: 25913 RICH SPRINGS CIRCLE STREET 2: C/O WEBMD CORP CITY: LA GUNS HILLS STATE: CA ZIP: 92653 FORMER NAME: FORMER CONFORMED NAME: DIMICK NEIL F DATE OF NAME CHANGE: 20030626 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 4 1 doc1.xml FORM 4 X0306 4 2012-12-19 0 0000069499 MYLAN INC. MYL 0001248380 DIMICK NEIL F 1500 CORPORATE DRIVE CANONSBURG PA 15317 1 0 0 0 Common Stock 2012-12-19 4 M 0 10000 20.86 A 36928 D Common Stock 2012-12-19 4 S 0 10000 27.8394 D 26928 D Common Stock 2012-12-19 4 M 0 10000 22.00 A 36928 D Common Stock 2012-12-19 4 S 0 10000 27.8394 D 26928 D Common Stock 2012-12-19 4 M 0 10000 15.80 A 36928 D Common Stock 2012-12-19 4 S 0 10000 27.8394 D 26928 D Stock Option Right to Buy 20.86 2012-12-19 4 M 0 10000 0 D 2005-11-28 2015-11-28 Common Stock 10000 0 D Stock Option Right to Buy 22 2012-12-19 4 M 0 10000 0 D 2006-07-28 2016-07-28 Common Stock 10000 0 D Stock Option Right to Buy 15.80 2012-12-19 4 M 0 10000 0 D 2007-07-27 2017-07-27 Common Stock 10000 0 D Represents the weighted price of the reporting person's disposition of 30,000 shares in transactions ranging from $27.51 to $28.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. This option exercise and the related sale were executed pursuant to a 10b5-1 trading plan dated December 12, 2012. /s/ Neil F. Dimick 2012-12-21